Subgroups, reanalyses, and other dangerous things

Annals of Emergency Medicine

Volumn 46, Issue 3, 2005, Pages 253-255

  Wears, Robert L ^a,b,e   Cooper, Richelle J ^c   Magid, David J ^d  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d CLINICAL RESEARCH UNIT   (United States)

^e UNIVERSITY OF FLORIDA HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; FIBRINOLYTIC AGENT;

CLINICAL OBSERVATION; COMPARATIVE STUDY; CONTROLLED STUDY; DATA ANALYSIS; DISEASE SEVERITY; DRUG EFFICACY; EDITORIAL; FIBRINOLYTIC THERAPY; HEART INFARCTION; HUMAN; HYPERTENSION; PERCUTANEOUS CORONARY INTERVENTION; POPULATION; PRIORITY JOURNAL; REPERFUSION; SAMPLE SIZE; SEX; ST SEGMENT ELEVATION; STATISTICAL ANALYSIS; STROKE; SURVIVAL; THEORETICAL STUDY; TIME;

DATA INTERPRETATION, STATISTICAL; HUMANS; PATIENT SELECTION; RESEARCH DESIGN; SAMPLE SIZE;

EID: 24044538282     PISSN: 01960644     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.annemergmed.2005.05.007     Document Type: Editorial

References (18)

1. The National Institute of Neurological Disorders Stroke rt-PA Stroke Study Group Recombinant Tissue Plasminogen Activator for Minor Strokes: The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Experience Ann Emerg Med 46 2005 243 252
2. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group Tissue plasminogen activator for acute ischemic stroke N Engl J Med 333 1995 1581 1587
3. National Heart, Lung and Blood Institute Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure 2003 National Institutes of Health Bethesda, MD Available at: http://www.nhlbi.nih.gov/guidelines/hypertension/express.pdf
4. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2 J Am Coll Cardiol 12 6 suppl A 1988 3A 13A
5. Fibrinolytic Therapy Trialists' (FTT) Collaborative Group Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients Lancet 343 1994 311 322
6. A.R. Feinstein, and R.I. Horwitz Problems in the "evidence" of "evidence-based medicine." Am J Med 103 1997 529 535
7. D.A. Asch, and J.C. Hershey Why some health policies don't make sense at the bedside Ann Intern Med 122 1995 846 850
8. L.R. Wardrop Simpson's Paradox and the hot hand in basketball Am Stat 49 1995 24 28
9. S.F. Assmann, S.J. Pocock, and L.E. Enos Subgroup analysis and other (mis) uses of baseline data in clinical trials Lancet 355 2000 1064 1069
10. S.J. Pocock, T.J. Collier, and K.J. Dandreo Issues in the reporting of epidemiological studies: a survey of recent practice BMJ 329 2004 883 888
11. S.T. Brookes, E. Whitley, and T.J. Peters Subgroup analyses in randomised controlled trials: quantifying the risks of false positives and false negatives Health Technol Assess 5 2001 1 64
12. S.T. Brookes, E. Whitely, and M. Egger Subgroup analyses in randomized trials: risks of subgroup-specific analyses: power and sample size for the interaction test J Clin Epidemiol 57 2004 229 236
13. S. Yusuf, J. Wittes, and J. Probstfield Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials JAMA 266 1991 93 98
14. J.L. Mills Data torturing N Engl J Med 329 1993 1196 1199
15. T.A. Lang, and M. Secic The multiple testing problem How to Report Statistics in Medicine: Annotated Guidelines for Authors, Editors, and Reviewers 1997 American College of Physicians Philadelphia, PA 81 92
16. J.N.S. Matthews, and D.G. Altman Statistics notes: interaction 2: compare effect sizes not P values BMJ 313 1996 808
17. A.D. Oxman, and G.H. Guyatt A consumer's guide to subgroup analyses Ann Intern Med 116 1992 78 84
18. P.M. Rothwell Treating individuals 2: subgroup analysis in randomised controlled trials: importance, indications, and interpretation Lancet 365 2005 176 186